Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Jorge Esteban Villarrubia"'
Autor:
Jorge Esteban Villarrubia, Javier Torres Jiménez, Pablo Álvarez Ballesteros, Inmaculada Orejana Martín, Lucía Sanz Gómez, Juan José Soto Castillo, Elena Vida Navas, María Victoria San Román Gil, Javier Pozas Pérez, Ainara Soria Rivas
Publikováno v:
Medicina Clínica Práctica, Vol 4, Iss 3, Pp 100183- (2021)
Externí odkaz:
https://doaj.org/article/f0bc18a33c8a42b4a4490382943c6ee1
Autor:
Almudena Santón, Eugenia Olmedo, Tamara Caniego-Casas, Amparo Benito, Mónica García-Cosío, Jorge Esteban-Villarrubia, Pilar Garrido, José Palacios
Publikováno v:
Human Pathology Reports, Vol 28, Iss , Pp 300625- (2022)
Reliable neurotrophin kinase (NTRK) fusion assessment is of special relevance since durable responses to targeted therapies have been observed regardless tumor type, NTRK gene or fusion partner. The most prevalent NTRK fusion in solid tumors is the E
Externí odkaz:
https://doaj.org/article/3478181e0a73407eb952a2557503bfc3
Publikováno v:
Cancers. 14(15)
Colorectal cancer (CRC) is the third most common cancer in terms of incidence rate in adults and the second most common cause of cancer-related death in Europe. The treatment of metastatic CRC (mCRC) is based on the use of chemotherapy, anti-vascular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4ea5b4d7605a07023163f96a9de7751
https://pubmed.ncbi.nlm.nih.gov/35954382
https://pubmed.ncbi.nlm.nih.gov/35954382
Autor:
A Benito-Berlinches, A Soria-Rivas, Jorge Esteban-Villarrubia, A Cortés-Salgado, Y Lage-Alfranca, P Garrido-López, L Gorospe-Sarasua, P García-Abellás, A Gómez-Rueda, Javier Torres-Jiménez, M E Olmedo-García, P Gajate-Borau, E Corral-de la Fuente
Publikováno v:
Clinical and Translational Oncology. 23:1474-1480
Immune checkpoint inhibitors (ICI) have been associated with several immune-related adverse events, including sarcoidosis-like reactions (SLR). SLR, which has a low prevalence but an increasing incidence, is similar to sarcoidosis in terms of histolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::931dbb942ed1d1c396a7d61dd87e4f39
https://doi.org/10.1007/s12094-020-02546-w
https://doi.org/10.1007/s12094-020-02546-w
Autor:
Jorge Esteban Villarrubia, Lucía Carril-Ajuria, Alberto Carretero-González, Carmen Romero Ferreiro, Pablo Álvarez, Maria Ruiz-Vico, Daniel Castellano, Guillermo de Velasco
Publikováno v:
Journal of Clinical Oncology. 41:682-682
682 Background: Localized and oligometastatic resectable renal cell carcinoma (RCC) have moderate to high rates of relapse after surgery and evidence regarding the efficacy of perioperative treatments is conflicting. The risk of relapse varies across
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd47173bb7344f6a20b07193a2030cd1
https://doi.org/10.1200/jco.2023.41.6_suppl.682
https://doi.org/10.1200/jco.2023.41.6_suppl.682
Autor:
María San-Román-Gil, Javier Torres-Jiménez, Javier Pozas, Jorge Esteban-Villarrubia, Víctor Albarrán-Fernández, Pablo Álvarez-Ballesteros, Jesús Chamorro-Pérez, Diana Rosero-Rodríguez, Inmaculada Orejana-Martín, Íñigo Martínez-Delfrade, Pablo Reguera-Puertas, Raquel Fuentes-Mateos, Reyes Ferreiro-Monteagudo
Publikováno v:
Cancers. 15:863
Colorectal cancer (CRC) is the third most frequent cancer and the second most common cause of cancer-related death in Europe. High microsatellite instability (MSI-H) due to a deficient DNA mismatch repair (dMMR) system can be found in 5% of metastati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a0c07e209b0202086857d831082d0fe
https://doi.org/10.3390/cancers15030863
https://doi.org/10.3390/cancers15030863
Autor:
Jorge Esteban-Villarrubia, Javier Torres-Jiménez, Carolina Bueno-Bravo, Rebeca García-Mondaray, José Daniel Subiela, Pablo Gajate
Publikováno v:
Cancers. 15:566
Cisplatin-based neoadjuvant chemotherapy followed by radical cystectomy is the current standard of care for muscle-invasive bladder cancer (MIBC). However, less than half of patients are candidates for this treatment, and 50% will develop metastatic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f4a578083ef10a9e2e1a157c3569d73
https://doi.org/10.3390/cancers15030566
https://doi.org/10.3390/cancers15030566
Autor:
Elena Vida Navas, Lucía Sanz Gómez, Pablo Álvarez Ballesteros, Javier Torres Jiménez, María Victoria San Román Gil, Inmaculada Orejana Martín, Ainara Soria Rivas, Javier Pozas Pérez, Jorge Esteban Villarrubia, Juan J. Castillo
Publikováno v:
Medicina Clínica Práctica, Vol 4, Iss 3, Pp 100183-(2021)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::777c6c268685e32e4f6ea245783ea44d
http://www.sciencedirect.com/science/article/pii/S2603924920301105
http://www.sciencedirect.com/science/article/pii/S2603924920301105
Autor:
J.J. Soto-Castillo, V. Albarrán Fernández, Aguilera Gómez, Javier Pozas, J. Chamorro-Pérez, Jorge Esteban-Villarrubia, L. Sanz-Gómez, P. Alvarez-Ballesteros, D.I. Rosero-Rodríguez, Javier Torres-Jiménez, Y. Lage, I. Orejana-Martín, P. Garrido Lopez, Maria Eugenia Olmedo Garcia, E. Corral de la Fuente, A. Benito Berlinches, E.M. Vida-Navas, M. San Roman-Gil
Publikováno v:
Annals of Oncology. 32:S918-S919
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40bc8395e1ea882abfcc71df5d1e3e3e
https://doi.org/10.1016/j.annonc.2021.08.199
https://doi.org/10.1016/j.annonc.2021.08.199
Autor:
María San Román-Gil, Javier Pozas, Inmaculada Orejana-Martín, Javier Torres-Jiménez, Juan José Soto-Castillo, Alfredo Carrato, Teresa Alonso-Gordoa, Javier Molina-Cerrillo, Jorge Esteban-Villarrubia
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 8529, p 8529 (2020)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
Tyrosine kinase receptors (TKR) comprise more than 60 molecules that play an essential role in the molecular pathways, leading to cell survival and differentiation. Consequently, genetic alterations of TKRs may lead to tumorigenesis and, therefore, c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5553703d206c4c2e510900bbd5e7ca7
https://www.mdpi.com/1422-0067/21/22/8529
https://www.mdpi.com/1422-0067/21/22/8529